Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed
United Airlines raises spending requirements to earn frequent flyer status
Pending home sales took an unexpected leap higher last month, but rates have climbed back up
Airbus delivers first extra-long-range Airbus A321 as smaller jets fly farther
Starbucks will discontinue Oleato olive oil drinks at U.S. cafes in early November
$2 billion marina development aims to turn Fort Lauderdale into 'mini Monaco'
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
